Triasima Portfolio Management’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$755K Buy
3,420
+780
+30% +$216K 0.1% 110
2026
Q1
$780K Buy
2,640
+167
+7% +$49.6K 0.12% 109
2025
Q4
$675K Hold
2,473
0.1% 112
2025
Q3
$668K Buy
+2,473
New +$673K 0.1% 122

Other funds holding CME

Triasima Portfolio Management's CME Position: Q2 2026 in Review

Triasima Portfolio Management increased its CME Group (CME) stake by 30% in Q2 2026, buying an estimated $216K and bringing the position to 3,420 shares worth $755K. The position accounts for 0.1% of the portfolio, ranked #110.

Triasima Portfolio Management first reported a position in CME in Q3 2025 and has held it in 4 quarters since. The position peaked at $780K in Q1 2026. 1,698 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Triasima Portfolio Management held 3,420 shares of CME Group worth $755K as of Q2 2026.
  • Triasima Portfolio Management bought 780 CME Group shares in Q2 2026, an estimated $216K.
  • CME Group made up 0.1% of Triasima Portfolio Management's portfolio in Q2 2026, its #110 holding.
  • Triasima Portfolio Management first reported a position in CME Group in Q3 2025 and has held it in 4 quarters since.
  • Triasima Portfolio Management's CME Group position peaked at $780K in Q1 2026.
  • 1,698 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Triasima Portfolio Management's 13F filing for Q2 2026, filed 21 Jul 2026.